secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001104659-25-088238
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Roger Dansey and Hervé Hoppenot to Board of Directors
--------------------------------------------------------------------------------

- Roger Dansey, M.D. (ex-Pfizer/Seagen) and Hervé Hoppenot (ex-Incyte/Novartis) joined the board effective Sep 8, 2025.
- Board expanded from 8 to 10 members; Dr. Dansey serves as Class III director, Mr. Hoppenot as Class I director.
- Both are independent; Dr. Dansey will serve on Scientific and Nominating/Governance committees, Mr. Hoppenot on Audit and Compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/0001104659-25-088238-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/tm2525491d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-088238

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer